Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

Summary

This study is designed to address the feasibility of a randomized, double masked, cross-over study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).

Timeline

Start

2019-07-26

Primary completion

2021-01-01

Completion

2021-01-01

Publications

• Curtis SA, Jhawar R, Bellis J, McCuskee S, Devine L, Roberts JD. A pilot study of dronabinol for the treatment of pain in sickle cell disease. Pilot Feasibility Stud. 2025 Nov 12;11(1):139. doi: 10.1186/s40814-025-01705-6.

Drugs

Indications